| Crohn Disease |
1 |
1 |
| Stem Cell Research and Therapy |
0 |
0.99 |
| Fistula |
0 |
0.73 |
| Rectovaginal Fistula |
0 |
0.56 |
| Transplantation |
0 |
0.4 |
| Inflammatory Bowel Disease |
0 |
0.39 |
| Anaphylaxis |
0 |
0.27 |
| Graft Versus Host Disease and Transplant Complications |
0 |
0.27 |
| Renal Failure |
0 |
0.27 |
| Biologic Therapy |
0 |
0.22 |
| Colitis |
0 |
0.2 |
| Refractory |
0 |
0.2 |
| Wound Management |
0 |
0.19 |
| Graft Versus Host Disease |
0 |
0.14 |
| Pancytopenia |
0 |
0.14 |
| Acute Kidney Injury |
0 |
0.13 |
| Clinical Research |
0 |
0.13 |
| Flap Advancement |
0 |
0.13 |
| Graft |
0 |
0.13 |
| Resection |
0 |
0.13 |
| Tissue |
0 |
0.13 |
| Urinary Tract Infection |
0 |
0.13 |
| Dermatologic Surgery |
0 |
0.12 |
| Ulcerative Colitis |
0 |
0.12 |
| Pregnancy |
0 |
0.1 |
| Bone Marrow |
0 |
0.09 |
| Colorectal Surgery |
0 |
0.09 |
| Healthcare and Medical Technology |
0 |
0.09 |
| Hemorrhagic Cystitis |
0 |
0.09 |
| Perianal Abscess |
0 |
0.09 |
| Skin and Soft Tissue Infection |
0 |
0.09 |
| Umbilical Cord |
0 |
0.09 |
| Veno-Occlusive Hepatic Disease |
0 |
0.09 |
| Abscess |
0 |
0.07 |
| Antigens |
0 |
0.07 |
| Board Certification |
0 |
0.07 |
| Bone |
0 |
0.07 |
| California |
0 |
0.07 |
| Cystitis |
0 |
0.07 |
| Cytokines |
0 |
0.07 |
| Grant |
0 |
0.07 |
| Ileum |
0 |
0.07 |
| Incontinence |
0 |
0.07 |
| Injury |
0 |
0.07 |
| Ischemia |
0 |
0.07 |
| Kidney |
0 |
0.07 |
| Liver |
0 |
0.07 |
| Mucositis |
0 |
0.07 |
| Pain |
0 |
0.07 |
| Pennsylvania |
0 |
0.07 |
| Remission |
0 |
0.07 |
| Spain |
0 |
0.07 |
| Steroids |
0 |
0.07 |
| Surgery |
0 |
0.07 |
| Umbilical |
0 |
0.07 |
| Pain Management |
0 |
0.04 |